Ранний псориатический артрит

1. <div><p>Moll J.M.H., Wright V. Psoriatic arthritis. Semin. Arthr. Rheum., 1973,3,55— 78.</p><p>Kaipiainen -Seppanen O. Incidence of psoriatic arthritis in Finland. Br. J. Rheumatol, 1996,35( 12), 1289— 91.</p><p>Shbeeb М., Uramoto K.M., Gibson L.E. et at. The epidemiology of psoriatic arthritis in Olmsted County, Minnesota, USA, 1982—1991. J. Rheumatol., 2000,27(5), 1247-50.</p><p>Soderlin M.K., Borjesson 0., Kautiainen H. et al. Annual incidence of inflammatory joint diseases in a population based study in southern Sweden. Ann. Rheum. Dis., 2002,61(10),911- 5.</p><p>Alamanos Y., Papadopoulos N.G., Voulgari P. V. et al. Epidemiology of psoriatic arthritis in northwest Greece, 1982-2001. J. Rheumatol., 2003,30(12),2641- 4.</p><p>Gladman D., Espinoza L. International symposium on psoriatic arthritis. J. Rheumatol., 1992,19,290—1.</p><p>O'Neill Т., Silman A.J. Psoriatic arthritis. Historical background and epidemiology. Baillieres Clin. Rheumatol., 1994.8(2),245-61.</p><p>Salvarani C., Lo Scocco G., Macchioni P. et al. Prevalence of psoriatic arthritis in Italian psoriatic patients. J. Rheumatol., 1995,22,1499-503.</p><p>Harrison B.J., Silman A.J., Barrett E. M. etal. Presence of psoriasis does not influence the presentation or short-term outcome of patients with early inflammatory polyarthritis. J. Rheumatol., 1997,24(9), 1744—9.</p><p>Kane D., Stafford L., Bresnihan B. FitzGerald O. A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience. Rheumatology (Oxford), 2003,42(12), 1460— 8.</p><p>Gladman D.D. Natural history of psoriatic arthritis. Baillieres Clin. Rheumatol., 1994,8(2),379- 94.</p><p>Gladman D.D., Farewell V.T., Wong K., Husted J. Mortality studies in psoriatic arthritis: results from a single outpatient center. II. Prognostic indicators for death. Arthr. Rheum., 1998,41(6), 1103—10.</p><p>McHugh N. Balachrishnan C., Jones S. Progression of peripheral joint disease in PsA: a 5 year prospective study. Rheumatology, 2003,42,778-83.</p><p>Stafford L., Kane D., Murphy E. et al. Psoriasis predicts a poor short-term outcome in patients with spon- dylarthropaty. Arthr. Rheum., 2001,45,485—93.</p><p>Taylor W, Gladman D., HelliwellP. etal. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthr. Rheum., 2006,54,2665-73.</p><p>Chandran V. Schentag C.T., Gladman D. CASPAR criteria are sensitive in early psoriatic arthritis (PsA) and are accurate when applied to patients attending a family practice clinic /abstract/. Ann. Rheum. Dis., 2007,66,suppl 11,415.</p><p>Olivieri I., DAngelo S., Padula A., Palazzi C. The challenge of early diagnosis of psoriatic arthritis. J. Rheumatol., 2008,35(1),3-5.</p><p>Punzi L., Pianon М., Rossini P. et al. Clinical and laboratory manifestations of elderly onset psoriatic arthritis: a comparison with younger onset disease. Ann. Rheum. Dis., 1999,58(4),226- 9.</p><p>Lindqvist U., Alenius G-М., Husmark T. et al. The swedish early psoriatic arthritis register — 2-year fol- lowup: a comparison with early rheumatoid arthritis. J. Rheumatol., 2008,35(4),668-73.</p><p>Jones S.М., Armas J.B., Cohen M.G. et al. Psoriatic arthritis: outcome of disease subsets and relationship of joint disease to nail and skin disease. Br. J. Rheumatol., 1994,33(9),834 -9.</p><p>Kane D., Stafford L., Bresnihan B., FitzGerald O. A classification study of clinical subsets in an inception cohort of early psoriatic peripheral arthritis— DIP or not DIP revisited'. Rheumatology (Oxford), 2003,42(12), 1469- 76.</p><p>Khan М., Schentag C., Gladman D.D. Clinical and radiological changes during psoriatic arthritis disease progression. J. Rheumatol., 2003,30(5), 1022-6.</p><p>Gladman D., Stafford-Brady F., Chang C. et al. Longitudinal study of clinical and radiological progression in psoriatic arthritis. J. Rheumatol. 1990,17,80912.</p><p>Torre Alonso J.C. Rodriguez Perez A., Arribas Castrillo J. M. et al. Psoriatic arthritis (PA): a clinical, immunological and radiological study of 180 patients. Br. J. Rheumatol., 1991,30,245-50.</p><p>Rahman P., Nguyen E., Cheung C. et at. Comparison of radiological severity in psoriatic arthritis and rheumatoid arthritis. J. Rheumatol., 2001,28,1041-4.</p><p>Armstrong R.D., Panayi G.S., Welsh K.l. Histocompatibility antigens in psoriasis, psoriatic arthropathy, and ankylosing spondylitis. Ann. Rheum. Dis., 1983,42(2), 142-6.</p><p>Woodrow J.C., llchysyn A. HLA antigens in psoriasis and psoriatic arthritis. J. Med. Genet., 1985,22(6),492- 5.</p><p>Gladman D. D., Anhorn K.A., Schachter R.K., Mervart H. HLA antigens in psoriatic arthritis. J. Rheumatol., 1986,13(3),586- 92.</p><p>Murray C., Mann D.L., Gerber L.N. et a I. Histocompatibility alloantigens in psoriasis and psoriatic arthritis. Evidence for the influence of multiple genes in the major histocompatibility complex. J. Clin. Invest., 1980,66(4),670-5</p><p>Espinoza L.R., Vasey F.B., Oh J.H. et al. Association between HLA-BW38 and peripheral psoriatic arthritis. Arthr. Rheum., 1978,21(1),72-5.</p><p>Brewerton D.A., Caffrey М., Nicholls A. et al. HL-A 27 and arthropathies associated with ulcerative colitis and psoriasis. Lancet, 1974,1(7864), 956— 8.</p><p>Gerber L.H., Murray C.L., Perlman S.G. etal. Human lymphocyte antigens characterizing psoriatic arthritis and its subtypes. J. Rheumatol., 1982,9(5), 703- 7.</p><p>Marsal S., Armadans-Gil L., Martinez M. et al. Clinical, radiographic and HLA associations as markers for different patterns of psoriatic arthritis. Rheumatology (Oxford), 1999,38(4),332— 7.</p><p>Beaulieu A.D., Roy R., Mathon G. et al. Psoriatic arthritis: risk factors for patients with psoriasis — a study based on histocompatibility antigen frequencies. J. Rheumatol., 1983,10(4),633-6.</p><p>Gladman D.D., Farewell V.T. The role of HLA antigens as indicators of disease progression in psoriatic arthritis. Multivariate relative risk model. Arthr. Rheum., 1995,38(6),845- 50.</p><p>Balding J., Kane D., Livingstone W. et al. Cytokine gene polymorphisms: association with psoriatic arthritis susceptibility and severity. Arthr. Rheum., 2003,48(5), 1408- 13.</p><p>Veale D., Yanni G., Rogers S. et al. Reduced synovial membrane macrophage numbers, ELAM-1 expression, and lining layer hyperplasia in psoriatic arthritis as compared with rheumatoid arthritis. Arthr. Rheum., 1993,36(7), 893-900.</p><p>Reece R.J., Canete J.D., Parsons W.J. et al. Distinct vascular patterns of early synovitis in psoriatic, reactive, and rheumatoid arthritis. Arthr. Rheum., 1999,42(7), 1481-4.</p><p>Kane D., Gogarty М., O'Leary J. et al. Reduction of synovial sublining layer inflammation and proinflammatory cytokine expression in psoriatic arthritis treated with methotrexate. Arthr. Rheum., 2004,50(10),3286— 95.</p><p>Fraser A., Fearon U., Reece R. et at. Matrix metal- loproteinase 9, apoptosis, and vascular morphology in early arthritis. Arthr. Rheum., 2001,44(9),2024- 8.</p><p>Punzi L„ Pianon M„ Bertazzolo N. et al. Clinical, laboratory and immunogenetic aspects of post-traumatic psoriatic arthritis: a study of 25 patients. Clin. Exp. Rheumatol., 1998,16(3),277- 81.</p><p>Punzi L., Bertazzolo N., Pianon M. et al. Value of synovial fluid interleukin-1 beta determination in predicting the outcome of psoriatic monoarthritis. Ann. Rheum. Dis., 1996,55(9),642— 4.</p><p>Ritchlin C., Haas-Smith S.A., Hicks D. et al. Patterns of cytokine production in psoriatic synovium. J. Rheumatol., 1998,25(8),1544-52.</p><p>Partsch G., Wagner E., Leeb B.F. et al. Tcell derived cytokines in psoriatic arthritis synovial jluids. Ann. Rheum. Dis., 1998,57(11),691-3.</p><p>Mease P.J., Goffe B.S., Metz J■ et al. Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial. Lancet, 2000,356(9227),385—90.</p><p>Scarpa R., Oriente P., Pucino A. et at. Psoriatic arthritis in psoriatic patients. Br. J. Rheumatol., 1984,23(4),246- 50.</p><p>Olivieri I., Barozzi L., Favaro L. et al. Dactylitis in patients with seronegative spondylarthropathy. Assessment by ultrasonography and magnetic resonance imaging. Arthr. Rheum., 1996,39(9), 1524— 8.</p><p>Olivieri /., Barozzi L., Pierro A. et al. Toe dactylitis in patients with spondyloarthropathy: assessment by magnetic resonance imaging. J. Rheumatol., 1997,24(5),926-30.</p><p>Kane D., Greaney Т., Bresnihan B. et al. Ultrasonography in the diagnosis and management of psoriatic dactylitis. J. Rheumatol., 1999,26(8), 174651.</p><p>Salvarani C., Cantini F., Olivieri 1. et al. Isolated peripheral enthesitis and/or dactylitis: a subset of psoriatic arthritis. J. Rheumatol., 1997,24(6), 1106— 10.</p><p>Gladman D., Shuckett R., Russell M. et al. Psoriatic arthritis (PSA) — an analysis of 220 patients. Q. J. Med., 1987,62(238), 127-41.</p><p>Lambert J.R., Wright V. Psoriatic spondylitis: a clinical and radiological description of the spine in psoriatic arthritis. Q. J. Med., 1977,46( 184),411 — 25.</p><p>Hanly J.G., Russell M.L., Gladman D.D. Psoriatic spondyloarthropathy: a long term prospective study. Ann. Rheum. Dis., 1988,47(5),386- 93.</p><p>Salvarani C., Macchioni P., Cremonesi T. et al. The cervical spine in patients with psoriatic arthritis: a clinical, radiological and immunogenetic study. Ann. Rheum. Dis., 1992,51(1),73-7.</p><p>Gladman D.D., Brubacher B., Buskila D. et al. Psoriatic spondyloarthropathy in men and women: a clinical, radiographic, and HLA study. Clin. Invest. Med., 1992,15(4),371- 5.</p><p>Scatpa R., Cuocolo A., Peluso R. et at. Early psoriatic arthritis: the clinical spectrum. J. Rheumatol., 2008,35,137-41.</p><p>Palazzi C., D'Agostino L., D'Amico E. et al. Asymptomatic erosive peripheral psoriatic arthritis: a frequent finding in Italian patients. Rheumatology Oxford, 2003,42,909-11.</p><p>Helliwell P.S., Marchesoni A., Peters M. et al. Cytidine deaminase activity, С reactive protein, histidine, and erythrocyte sedimentation rate as measures of disease activity in psoriatic arthritis. Ann. Rheum. Dis., 1991,50(6),362-5.</p><p>Gladman D.D., Farewell V. Т. NadeauC. Clinical indicators of progression in psoriatic arthritis: multivariate relative risk model. J. Rheumatol., 1995,22(4),675- 9.</p><p>Fiocco U., Cozzi L., Ruhaltelli L. et al. Long-term sonographic follow-up of rheumatoid and psoriatic proliferative knee joint synovitis. Br. J. Rheumatol., 1996,35(2), 155- 63.</p><p>Backhaus М., Kamradt Т., Sandrock D. etal. Arthritis of the finger joints: a comprehensive approach comparing conventional radiography, scintigraphy, ultrasound, and contrast- enhanced magnetic resonance imaging. Arthr. Rheum., 1999,42(6), 1232—45.</p><p>Balint P.V., Kane D., Wilson H. et al. Ultrasonography of entheseal insertions in the lower limb in spondyloarthropathy. Ann. Rheum. Dis., 2002,61( 10),905—10.</p><p>D’Agostino М.A., Said-Naha! R., Hacquard-Bouder C. et al. Assessment of peripheral enthesitis in the spon- dylarthropathies by ultrasonography combined with power Doppler: a cross-sectional study. Arthr. Rheum., 2003,48(2),523-33.</p><p>Frediani B., Falsetti P., Storri L. etal. Ultrasound and clinical evaluation of quadricipital tendon enthesitis in patients with psoriatic arthritis and rheumatoid arthritis. Clin. Rheumatol., 2002,21(4),294— 8.</p><p>Gisondi P., Tinazzi /■, El-Da la ti et al. Lower limb enthesopathy in patients with psoriasis without clinical signs of arthropathy: a hospital-based case-control study. Ann. Rheum. Dis., 2008,67(1),26- 30.</p><p>Balint P.V., Sturrock R.D. Inflamed retrocalcaneal bursa and Achilles tendonitis in psoriatic arthritis demonstrated by ultrasonography. Ann. Rheum. Dis., 2000,59(12), 931- 3.</p><p>McGonagle D., Conaghan P.G., Emeiy P. Psoriatic arthritis: a unified consept twenty years on. Arthr. Rheum., 1999,42(6), 1080-6.</p><p>McGonagle D., Gibbon W., O’Connor P. et al. Characteristic magnetic resonance imaging entheseal changes of knee synovitis in spondy/arthropathy. Arthr. Rheum., 1998,41(4),694- 700.</p><p>AlasaarelaE., Suramo 1., TervonenO. etal. Evaluation of humeral head erosions in rheumatoid arthritis: a comparison of ultrasonography magnetic resonance imaging, computed tomography and plain radiography. Br. J. Rheumatol., 1998,37(11), 1152- 6.</p><p>Raza N. Hameed A., Ali M.K. Detection of subclini- cal joint involvement in psoriasis with bone scintigraphy and its response to oral methotrexate. Clin. Exp. Dermatol., 2007, Dec 10.</p><p>Emery P. The Roche Rheumatology Prize Lecture. The optimal management of early rheumatoid disease: the key to preventing disability. Br. J. Rheumatol., 1994,33(8), 765- 8.</p><p>Kane D., Pathare S. Early psoriatic arthritis. Rheum. Dis. Clin. North Am., 2005,31,641-57.</p><p>Fraser S.М., Hopkins R., Hunter J.A. et al. Sulphasalazine in the management of psoriatic arthritis. Br. J. Rheumatol., 1993,32(10),923— 5.</p><p>Combe B., Goupille P., KuntzJ L. etal. Sulphasalazine in psoriatic arthritis: a randomized, multicentre, placebo-controlled study. Br. J. Rheumatol., 1996,35(7),664-8.</p><p>Farr М., KitasG.D., Waterhouse L. et al. Treatment of psoriatic arthritis with sulphasalazine: a one year open study. Clin. Rheumatol., 1988,7(3),372-7.</p><p>Clegg D.O., Reda D.J., Mejias E. et at. Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis. A Department of Veterans Affairs Cooperative Study. Arthr. Rheum., 1996,39(12),2013- 20.</p><p>Cuellar M.L., Espinoza L.R. Methotrexate use in psoriasis and psoriatic arthritis. Rheum. Dis. Clin. North Am., 1997,23(4), 797- 809.</p><p>Kaltwasser J.P., Nash P., Gladman D. et al. Efficacy and safety of leflunomide in the treatment of psoriatic arthritis and psoriasis: a multinational, double-blind, randomized, placebo-controlled clinical trial. Arthr. Rheum., 2004,50(6), 1939- 50.</p><p>Fraser A. D., van Kuijk A.W., Westhovens R. et al. A randomised, double-blind, placebo controlled, multicentre trial of combination therapy with methotrexate plus cyclosporin in patients with active psoriatic arthritis. Ann. Rheum. Dis., 2005,64(6),859- 64[20041.</p><p>Jones G., Crotty М., Brooks P. Psoriatic arthritis: a quantitative overview of therapeutic options. The Psoriatic Arthritis Meta-Analysis Study Group. Br. J. Rheumatol., 1997,36(1),95 - 9.</p><p>Antoni C., Krueger G.G., de Vlam K. et al. Infliximab impivves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial. Ann. Rheum. Dis., 2005,64(8), 1150- 7.</p><p>Braun J., Sieper J. Biological therapies in the spon- dyloarthritides—the current state. Rheumatology (Oxford), 2004,43(9), 1072- 84.</p></div><br />